Pay in 4 interest-free payments of $5.57 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
In adults with obesity, a weekly 2.4 mg dose led to about 15% body weight lost over 68 weeks
Confirm the specific terms before relying on this as a safety net
NEJM, 389, 22212232
In SUSTAIN-7, a study comparing semaglutide to dulaglutide in patients with inadequately controlled T2DM, a greater reduction in body weight was observed with 0.5 mg semaglutide (4.6 kg, standard error [SE] 0.28) compared with 0.75 mg dulaglutide (2.3 kg, SE 0.27) (estimated treatment difference [ETD] 2.26 kg, 95% CI 3.02 to 1.51
US$ 23.87
US$ 25.83
US$ 26.06
